Baudax Bio Inc. (BXRX) PT Raised to $12 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell raised the price target on Baudax Bio Inc. (NASDAQ: BXRX) to $12.00 (from $8.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
